Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLH | Q9Y253 | 9/20 | 1.00 |
| ▸ | MEN1 | O00255 | 7/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.75 |
| ▸ | RECQL | P46063 | 4/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.75 |
| ▸ | MAPT | P10636 | 4/20 | 0.75 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.75 |
| ▸ | IPMK | Q8NFU5 | 4/20 | 0.75 |
| ▸ | IP6K2 | Q9UHH9 | 4/20 | 0.75 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.75 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.75 |
| ▸ | NOX4 | Q9NPH5 | 4/20 | 0.75 |
| ▸ | POLB | P06746 | 3/20 | 0.75 |
| ▸ | GAA | P10253 | 3/20 | 0.75 |
| ▸ | TP53 | P04637 | 3/20 | 0.75 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.75 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13776268 | 0.90 | POLH (0.82) | POLHMEN1KMT2AKDM4EHSD17B10 | |
| SCHEMBL6140182 | 0.89 | POLH (0.80) | POLHMEN1KMT2AKDM4EHSD17B10 | |
| SCHEMBL30819258 | 0.89 | POLH (0.80) | POLHMEN1KMT2AKDM4EHSD17B10 | |
| SCHEMBL13056253 | 0.88 | POLH (0.78) | POLHMEN1KMT2AKDM4EHSD17B10 | |
| SCHEMBL16682483 | 0.87 | POLH (0.77) | POLHMEN1KMT2AKDM4EHSD17B10 | |
| Quercetin SCHEMBL27746111 | 0.86 | MEN1 (0.94) | POLHMEN1KMT2AKDM4EHSD17B10 | |
| SCHEMBL30819237 | 0.86 | MEN1 (0.80) | POLHMEN1KMT2AKDM4EHSD17B10 | |
| SCHEMBL13552041 | 0.86 | MEN1 (0.76) | POLHMEN1KMT2AKDM4EHSD17B10 | |
| Quercetin SCHEMBL31507620 | 0.86 | MEN1 (1.00) | POLHMEN1KMT2AKDM4EHSD17B10 | |
| Quercetin SCHEMBL17629824 | 0.86 | MEN1 (1.00) | POLHMEN1KMT2AKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115120522-A | Composition containing luteolin and derivatives as effective components for promoting hair growth and application thereof | 浙江熙正霖生物科技有限公司 | 2022-09-30 | — | — | CN | claimed |
| CN-117740961-A | Compound analysis method of liquorice and liquorice probiotics fermentation preparation | 北京中医药大学 | 2024-03-22 | — | — | CN | disclosed |
| CN-117098460-A | Sweetener composition comprising mogrosides and uses thereof | 弗门尼舍公司 | 2023-11-21 | — | — | CN | disclosed |
| US-20230367223-A1 | SUBSTRATE PROCESSING COMPOSITION AND SUBSTRATE PROCESSING METHOD USING THE SAME | SK INC. (KR) | 2023-11-16 | — | — | US | disclosed |
| CN-116997263-A | Sweetener compositions comprising siamenoside I and uses thereof | 弗门尼舍公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-116963609-A | Sweetener composition comprising mogrosides and uses thereof | 弗门尼舍公司 | 2023-10-27 | — | — | CN | disclosed |
| EP-4215522-A1 | DERIVATIVES OF 4-CHROMONE AS INHIBITORS OF THE RDRP POLYMERASE OF SARS-COV-2 VIRUS AND METHOD FOR THE PREPARATION THEREOF | Fondazione Istituto Italiano di Tecnologia (IT) | 2023-07-26 | — | — | EP | disclosed |
| EP-4215522-A1 | DERIVATIVES OF 4-CHROMONE AS INHIBITORS OF THE RDRP POLYMERASE OF SARS-COV-2 VIRUS AND METHOD FOR THE PREPARATION THEREOF | Fondazione Istituto Italiano di Tecnologia (IT) | 2023-07-26 | — | — | EP | disclosed |
| US-20220387615-A1 | COMPOSITIONS COMPRISING ENZYME CLEAVABLE LINKER PLATFORMS AND CONJUGATES THEREOF | DANMARKS TEKNISKE UNIVERSITET (DK) | 2022-12-08 | — | — | US | disclosed |
| CN-115120522-A | Composition containing luteolin and derivatives as effective components for promoting hair growth and application thereof | 浙江熙正霖生物科技有限公司 | 2022-09-30 | — | — | CN | disclosed |
| US-20090304827-A1 | Combinations of Ingredients Having Synergistic Anti-Inflammatory Effects | KIM DARRICK S H L | 2009-12-10 | — | — | US | disclosed |
| US-20090143317-A1 | Quercetin Glycoside Composition and Method of Preparing the Same | SUNTORY LIMITED (JP) | 2009-06-04 | — | — | US | disclosed |
| WO-2009064485-A1 | ANTIOXIDANT FLAVONOID DERIVATIVES | TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2009-05-22 | — | — | WO | disclosed |
| US-20090083874-A1 | PRODUCTION OF PROANTHOCYANIDINS TO IMPROVE FORAGE QUALITY | THE SAMUEL ROBERTS NOBLE FOUNDATION | 2009-03-26 | — | — | US | disclosed |
| US-20090074708-A1 | Inhibitors and Enhancers of Uridine Diphosphate-Glucuronosyltransferase 2B (UGT2B) | NATIONAL DEFENSE MEDICAL UNIVERSITY (TW) | 2009-03-19 | — | — | US | disclosed |
| US-20080293644-A1 | GUAVA EXTRACT | OMNICA GMBH (DE) | 2008-11-27 | — | — | US | disclosed |
| US-20080214493-A1 | Use of Flavone Compounds as Potassium Channel Inhibitors | VERSITECH LIMITED (CN) | 2008-09-04 | — | — | US | disclosed |
| US-20080187622-A1 | Method for manufacturing alpha-glycosylisoquercitrin, intermediate product and by-product thereof | SAN-EI GEN F.F.I., INC. (JP) | 2008-08-07 | — | — | US | disclosed |
| US-20080182893-A1 | Prevention, therapy atherosclerosis; prevent plaque destabilization; using ienzyme modified soquercitrin | SAN-EI GEN F.F.I., INC. (JP) | 2008-07-31 | — | — | US | disclosed |
| US-20070248700-A1 | Extractions and Methods Comprising Elder Species | HERBALSCIENCE NUTRACEUTICALS, LLC | 2007-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090083874-A1 | PRODUCTION OF PROANTHOCYANIDINS TO IMPROVE FORAGE QUALITY | QPCTL, FABP6, HHAT | POLH 2017/4885MEN1 2562/4885KMT2A 2296/4885 |
| US-20080293644-A1 | GUAVA EXTRACT | DPP4, DPP8, DPP3 | POLH 4197/4885MEN1 3603/4885KMT2A 2143/4885 |
| US-20080214493-A1 | Use of Flavone Compounds as Potassium Channel Inhibitors | KCNN3, KCNN2, KCNN1 | POLH 4814/4885MEN1 2831/4885KMT2A 483/4885 |
| US-20220387615-A1 | COMPOSITIONS COMPRISING ENZYME CLEAVABLE LINKER PLATFORMS AND CONJUGATES THEREOF | ADAM17, ADAM8, ADAM33 | POLH 2194/4885MEN1 1111/4885KMT2A 2529/4885 |
| US-20090143317-A1 | Quercetin Glycoside Composition and Method of Preparing the Same | GANC, SI, AMY2A | POLH 1184/4885MEN1 3245/4885KMT2A 4617/4885 |
| US-20080182893-A1 | Prevention, therapy atherosclerosis; prevent plaque destabilization; using ienzyme modified soquercitrin | PCSK9, MMP1, IDE | POLH 584/4885MEN1 4337/4885KMT2A 4051/4885 |
| US-20070248700-A1 | Extractions and Methods Comprising Elder Species | NOP58, MYC, MDM4 | POLH 2012/4885MEN1 3162/4885KMT2A 3205/4885 |
| US-20090074708-A1 | Inhibitors and Enhancers of Uridine Diphosphate-Glucuronosyltransferase 2B (UGT2B) | UGT2B7, UGT2B17, UGT1A10 | POLH 1551/4885MEN1 4841/4885KMT2A 4826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.